S Kiraz
Overview
Explore the profile of S Kiraz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
672
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiraci M, Bilgin E, Duran E, Farisogullari B, Bolek E, Yardimci G, et al.
Scand J Rheumatol
. 2022 Dec;
52(5):530-538.
PMID: 36503416
Objective: To compare the demographic, clinical, and radiological features of patients with axial spondyloarthritis (axSpA) accompanying familial Mediterranean fever (FMF) to patients with each condition alone. Method: Hacettepe University Hospital...
2.
Batu E, Sari A, Erden A, Sonmez H, Armagan B, Kalyoncu U, et al.
Scand J Rheumatol
. 2018 Jun;
47(6):481-486.
PMID: 29912602
Objective: Immunoglobulin A vasculitis/Henoch-Schönlein purpura (IgAV/HSP) is a systemic vasculitis involving small vessels with the deposition of immune complexes containing IgA. It is the most common primary systemic vasculitis of...
3.
Batu E, Erden A, Seyhoglu E, Kilic L, Buyukasik Y, Karadag O, et al.
Scand J Rheumatol
. 2016 Jul;
46(1):44-48.
PMID: 27359073
Objectives: Reactive haemophagocytic syndrome (RHS) is a hyperinflammatory disorder often occurring in the background of several disorders such as infections, malignancies, and rheumatic diseases. Recently, a score known as the...
4.
Akdogan A, Kilic L, Akman U, Dogan I, Karadag O, Bilgen S, et al.
Lupus
. 2013 Jul;
22(8):835-8.
PMID: 23817512
Systemic lupus erythematosus (SLE) patients are at increased risk of thrombosis and cardiovascular diseases. Aspirin is an effective treatment option for these patients. The aim of this study was to...
5.
Ertenli I, Ozer S, Kiraz S, Apras S, Akdogan A, Karadag O, et al.
Rheumatol Int
. 2010 Nov;
32(2):323-30.
PMID: 21079965
The objective of this study was to assess the effect of infliximab on depression, anxiety and quality of life in patients with active ankylosing spondylitis (AS). In this 6-week longitudinal...
6.
Sinici I, Kalyoncu U, Karahan S, Kiraz S, Atalar E
Clin Exp Rheumatol
. 2010 Apr;
28(2):169-75.
PMID: 20406610
Objectives: An impaired availability of nitric oxide (NO), related to polymorphisms in endothelial nitric oxide synthase (eNOS) gene, may influence the microvasculature in systemic Sclerosis (SSc). Three potential eNOS gene...
7.
Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, et al.
Clin Exp Rheumatol
. 2009 Aug;
27(1 Suppl 52):S59-64.
PMID: 19646348
Objective: Takayasu's arteritis (TA) is a chronic, inflammatory vasculitis affecting the aorta and its major branches. Although it is more prevalent in Far-East Asia, the distribution of the disease is...
8.
Sahin N, Aksu K, Kamali S, Bicakcigil M, Ozbalkan Z, Fresko I, et al.
Rheumatology (Oxford)
. 2008 Apr;
47(5):634-5.
PMID: 18375974
Objective: Takayasu's arteritis (TA) is a chronic, rare granulomatous panarteritis of unknown aetiology involving mainly the aorta and its major branches. In this study, genetic susceptibility to TA has been...
9.
Onat A, Ozcakar L, Ozturk M, Ucar G, Ureten K, Dagli N, et al.
Clin Exp Rheumatol
. 2007 Nov;
25(4 Suppl 45):S16-20.
PMID: 17949546
Objective: Familial Mediterranean fever (FMF) is the most common auto-inflammatory syndrome with exaggerated acute phase and inflammatory response. After revealing the MEFV gene mutation with the finally disturbed end product...
10.
Cobanoglu N, Ozcelik U, Kalyoncu U, Ozen S, Kiraz S, Gurcan N, et al.
Int J Tuberc Lung Dis
. 2007 Oct;
11(11):1177-82.
PMID: 17958978
Objectives: Patients who receive tumour necrosis factor-alpha (TNF-alpha) blockers are mostly immunosuppressed. A study was performed to investigate whether an interferon-gamma (IFN-gamma) assay could represent an alternative approach to the...